OBJECTIVES: Coronary artery bypass grafting using saphenous vein grafts (SVGs) in addition to the left internal mammary artery (IMA) graft is vitiated by poor long-term patency of the vein grafts. Hypothetically, the increased use of arterial grafts could confer even better outcomes. Our goal was to evaluate results after coronary artery bypass grafting in Sweden, where arterial grafts were used as a second conduit.
INTRODUCTION
Coronary artery bypass grafting (CABG) is the recommended treatment for coronary artery disease (CAD) involving multiple vessels or the left main stem, with a survival benefit compared with that of percutaneous coronary intervention [1, 2] . Saphenous vein grafts (SVGs) are most often used but are subject to graft disease [3] , and their reduced long-term patency and outcome compared with left internal mammary artery (IMA) grafts are well established [4, 5] . This situation has sparked interest in the use of arterial conduits for multiple target vessels, supported by studies indicating better patency and improved survival compared with an SVG [6, 7] . The majority of operations are, however, still performed using an SVG [8, 9] , perhaps because of a lack of conclusive evidence of a superior overall outcome with alternative arterial grafts.
The Swedish personal identity number allows access to nationwide registries with the possibility of long-term follow-up. The Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) registry [10] provides data on all patients undergoing cardiac surgery in Sweden as well as records of angiograms and coronary interventions. The mortality rate yields limited information when used as the sole outcome in studies of graft patency, because it is probably only minimally influenced by the effects of failing grafts after CABG surgery [11] . In this study, we used the incidence of clinically driven angiography and the need for repeat interventions as end-points in addition to the mortality rate, because these outcomes are likely to have a high association with symptomatic graft failure and related events. We evaluated outcomes in more than 48 000 patients who had CABG using the IMA and the SVG, the radial artery (RA) or the additional IMA as a second conduit during the last 15 years in an observational study. Our goal was to determine the mortality rate, the incidence of a first angiogram and the need for repeat intervention and to estimate possible differences in outcomes between groups where different types of grafts were used to assess the potential benefits of more frequent use of arterial grafts.
PATIENTS AND METHODS

Data sources and study population
The study was approved by the regional Human Research Ethics Committee, Uppsala, Sweden. Patients between 40 years and 80 years of age with no congenital malformations and with a permanent residence in Sweden who underwent isolated CABG in Sweden between 2001 and 2015 were identified in the SWEDEHEART registry. We excluded patients who previously had cardiac surgery, where no IMA was used or the types of grafts were unknown; patients operated using a single IMA as the only graft; patients in whom coronary endarterectomy was performed and patients for whom arterial grafts other than the IMA or the RA were used (Fig. 1) . We obtained baseline characteristics at the time of the operation and data on all postoperative angiograms for included individuals.
Outcomes
The date of death was obtained from the national population registry. The dates for all operations and postoperative angiograms were available in the SWEDEHEART registry. For each angiogram, the indication for the procedure; the presence of significantly stenosed or occluded grafts and the subsequent therapeutic decision, including recommendations for revascularization, were registered by the angiographer. The elapsed times from the operation to death to the first clinically driven angiogram or the first need for reintervention were used as end-points. The only patients who are believed to have been lost to follow-up were those having had angiography or reintervention outside of Sweden.
Statistical methods
Patient characteristics were described using frequencies and percentages for categorical variables and means and standard deviations for continuous variables. The outcome measures were evaluated in the population as the time from operation to death from any cause, to the first angiogram after the operation and to the first need for reintervention after the operation. Patients were followed up from the date of the operation until the date of death from any cause or to the end of the follow-up (05 May 2016). The cohort was divided into 3 groups according to the graft material used for the CABG operation:
1. IMA + SVG, where a single IMA graft and SVGs were used. 2. IMA + RA, where a single IMA graft and a single RA were used with the possible addition of SVGs. 3. Bilateral internal mammary artery (BIMA), where the BIMA grafts were used with the possible addition of RA or SVGs.
Data management and statistical analyses were performed using R version 3.1.3 (R Foundation for Statistical Computing, Vienna, Austria). The Kaplan-Meier method was used to illustrate cumulative survival and cumulative incidence of the first clinically driven postoperative angiogram and the first need for reintervention. The competing risk of death was not accounted for in the incidence calculations. The log-rank test was used to establish a difference between the survival and cumulative incidence curves for IMA + SVG and for the 2 groups with multiple arterial grafts. Cox regression was used to estimate the associations of the graft type used with all-cause mortality, incidence of the first angiographic examination and the need for repeat coronary intervention. The hazard ratios and 95% confidence intervals (CIs) for the different types of grafts were calculated unadjusted and adjusted for age, gender, number of grafted coronary arteries, body mass index, presence of diabetes, renal function, chronic obstructive pulmonary disease, peripheral vascular disease, neurological disability, left ventricular function, prior myocardial infarction, who had CABG operations, aged 40-80 years and without congenital malformations were included in the study database. We excluded redo operations, cases in which no IMA was used or for which graft information was missing, cases in which a single IMA was the only graft used, cases in which an endarterectomy or plasty was performed and cases in which arterial grafts other than an IMA or an RA were used. The remaining patients were divided into 3 groups according to the grafts used in addition to a single IMA. BIMA: bilateral internal mammary artery; CABG: coronary artery bypass grafting; IMA: internal mammary artery; RA: radial artery; SVG: saphenous vein graft.
previous percutaneous coronary intervention, emergency surgery (beginning before the next working day after the decision) and an operation without cardiopulmonary bypass. Missing data were assumed to be missing at random and were imputed in 15 iterations by multiple imputations by chained equations using the R package 'mice'. Cox regression coefficients were calculated for each of the imputed data sets with the 'survival' R package, and regression results were pooled with the help of the 'mice' R package. A complete case analysis showed results similar to those obtained from the main analysis of the imputed data sets. Smoothed scaled Schoenfeld residual plots were used to assess the proportional hazards assumption graphically for each variable, and no important violation was found. Indications for the first angiogram and for the presence of stenosed grafts were described using frequencies and percentages. The P-values of <0.05 and 95% CIs were used to establish a statistically significant difference between groups.
RESULTS
Study population and baseline characteristics
In total, 54 804 Swedish residents between 40 years and 80 years of age without congenital malformations underwent isolated CABG in Sweden between January 2001 and December 2015. After exclusion, the study population comprised 46 343 cases of IMA + SVG, 1036 cases of IMA + RA grafts and 862 cases of BIMA grafts ( Fig. 1 ). An additional RA was used in 78 of the BIMA cases. The mean follow-up time (SD) was 9.3 (4.2) years for IMA + SVG, 10.7 (4.1) years for IMA + RA grafts and 5.5 (5.0) years for BIMA grafts. Baseline characteristics and early postoperative complications for the 3 groups are listed in Table 1 .
Mortality
The 30-day mortality rate was 1.2% for IMA + SVG, 0.8% for IMA + RA grafts and 0.8% for BIMA grafts. Death occurred in 25.8% (11 962/46 343) of the IMA + SVG patients, 27.1% (281/1036) of the IMA + RA patients and 11.9% (103/862) of the BIMA patients during the follow-up period. The survival (95% CI) rate at 10 years was 73.4% (73.0-73.9), 77.1% (74.1-79.8), and 77.0% (71.9-81.3), respectively, for the 3 groups (Fig. 2) . The log-rank test resulted in a P-value of 0.0006. When comparing pairwise with IMA + CABG, the P-values were 0.011 for the IMA + RA grafts and 0.003 for the BIMA grafts. The hazard ratio for death adjusted for risk factors compared with IMA + SVG was (95% CI) 1.01 (0.89-1.14) for the IMA + RA grafts and 0.87 (0.72-1.06) for the BIMA grafts ( Table 2) . The full regression model is available as a Supplementary Material, Fig. S1 .
Clinically driven angiography
Postoperative clinically driven angiography was performed in 18.3% (8498/46 343) of the IMA + SVG patients, 21.5% (223/1036) of the IMA + RA patients and 14.7% (127/862) of the BIMA patients. The cumulative incidence (95% CI) at 10 years for the first clinically driven postoperative angiogram was 21.9% (21.4-22.4), 22.4% (19.7-25.5), and 26.1% (21.5-31.3), respectively, for the 3 groups (Fig. 2) . The log-rank test resulted in a P-value of 0.054. When compared pairwise with IMA + CABG, the P-values were 0.62 for the IMA + RA grafts and 0.018 for the BIMA grafts. The hazard ratio for the first angiogram adjusted for risk factors compared with IMA + SVG was (95% CI) 0.96 (0.84-1.10) for the IMA + RA grafts and 1.13 (0.95-1.35) for the BIMA grafts (Table 2) .
Reintervention
A need for reintervention occurred in 10.1% (4661/46 343) of the IMA + SVG patients, 11.5% (119/1036) of the IMA + RA graft patients and 8.9% (77/862) of the BIMA graft patients. The cumulative incidence (95% CI) at 10 years for the need for reintervention was 11.6% (11.2-12.0), 11.9% (9.8-14.6), and 15.5% (12.0-19.9), respectively, for the 3 groups (Fig. 2) . The log-rank test resulted in a P-value of 0.015. When compared pairwise with IMA + CABG, the P-values were 0.93 for IMA + RA and 0.004 for BIMA. The hazard ratio for the need for reintervention adjusted for risk factors compared with IMA + SVG was (95% CI) 0.91 (0.75-1.09) for the IMA + RA grafts and 1.26 (1.00-1.58) for the BIMA grafts (Table 2) .
Indications for angiography and the occurrence of failed grafts ST-segment elevation myocardial infarction was the indication for the first angiogram in 5.7% of the IMA + SVG patients, 4.5% of the IMA + RA graft patients and 7.9% of the BIMA graft patients (Table 3) . Failed grafts were found on the first angiogram in 52.3% of the IMA + SVG patients, 54.4% of the IMA + RA graft patients and 54.5% of the BIMA graft patients (Table 3) .
DISCUSSION
Because the BIMA and RA grafts are rarely used in Sweden, few surgeons have experience in using these grafts. There is a possible over-representation of patients with no suitable vein graft material in the BIMA and the RA graft groups, because poor veins may have been a factor driving the decision to use alternative conduits to complement or replace SVG; however, both the RA and the BIMA graft groups included patients who had SVG in addition to the second arterial graft. There is also a probable selection bias in that healthier patients tend to be operated using arterial grafts. Neither the configuration of the grafts (e.g. sequential or y grafts) nor the targeted vessels can be identified in the registry. The degree of obstruction of the target vessels is also unknown. It was assumed that the second arterial graft was used for the most important target vessel second to LAD. There was no formal definition of an occluded or significantly stenosed graft, and it was completely operator dependent. Data on graft failure were not available for an individual graft, and there was no information from the angiographic procedure regarding the number of failed grafts, their targets or the type of graft. It is impossible to establish when a graft failed, what type it was or whether the presence of the failed graft in any way was a contributing cause of the symptoms preceding angiography. The use of the BIMA graft has been identified as an important risk factor for sternal wound infections [12] . In the SWEDEHEART registry, there is no clear definition of this complication, and these data are considered inaccurate.
In this study, we present follow-up data after CABG from a large Swedish data registry and evaluate long-term results. We compared patients operated using the SVG, the RA and the right IMA as a second conduit with regard to mortality, clinically driven angiography and reintervention. The groups with arterial grafts did not demonstrate better results than the IMA + SVG group for any of the studied end-points.
There is an ongoing discussion about the benefits of arterial grafting and a general interest in using more arterial grafts for CABG. The expectations are that arterial grafts should confer improved long-term outcome compared with the SVG, because the arterial grafts are thought to be more resilient to graft disease affecting SVG [3] and have demonstrated better patency [13, 14] . Data from non-randomized studies have indicated that the use of the BIMA graft is associated with improved long-term survival and fewer non-fatal events such as myocardial infarction and the need for reoperation [6] . A randomized trial has demonstrated improved clinical outcome of BIMA grafting [15] ; however, this BIMA: bilateral internal mammary artery; CABG: coronary artery bypass grafting; CC: creatinine clearance; CI: confidence interval; COPD: chronic obstructive pulmonary disease; IMA: internal mammary artery; MI: myocardial infarction; PCI: percutaneous coronary intervention; RA: radial artery; SD: standard deviation; SVG: saphenous vein graft.
could not be observed during the first 5 years after surgery in a later study [16] . Similar promising improvements in long-term results have been seen in non-randomized studies of RA grafting [17] as well as in randomized trials [15] . An improved long-term survival rate in the Swedish CABG population who received arterial grafts as a second conduit could be expected, because these patients were overall somewhat younger and healthier than those in the population receiving the SVG. The mortality rate for the first 5 years after surgery was similar for the 3 groups. Interestingly, the differences between the groups started to become apparent after 5 years, when it would be expected that the vein grafts would start to fail. However, the observed improved survival rate seen in the IMA + RA and BIMA group disappeared when the data were adjusted for risk factors.
In this study, we used the incidence of the first clinically driven angiogram and the need for repeat intervention as end-points, because they are likely to have a high correlation with symptomatic graft failure. There are a few other registry-based studies of these end-points. The outcome was similar for the IMA + SVG and IMA + RA but there seems to be a trend towards a higher incidence of angiography and a higher incidence of reintervention in the BIMA group. It appears that this difference in incidence is established during the first 2 years after surgery and then remains stable. An explanation for this result could be that the BIMA grafting is technically more challenging, especially in a setting in which it is rarely performed, leading to more technical failures and a subsequent early postoperative presentation of symptoms, need for investigation and reintervention. Regardless of possible differences in the rates of early angiography and intervention after arterial grafting, the overall mortality rate and incidence of angiography and reintervention beyond the first years after surgery do not support the view that the beneficial effects of multiple arterial grafting will become apparent at least during the first 10-15 years after surgery. The incidence of angiography may reflect the return of CAD symptoms, but it is influenced by factors such as rates of surveillance with functional studies and physician threshold for repeat angiography versus optimization of medical therapy. There could be different thresholds for different groups of patients, and these could be changing over time. We observed a difference in followup times between the groups. Because the type of grafting used is influenced by local surgical tradition, these patients are not evenly distributed over all centres in Sweden. To get an indication whether the threshold for investigation tended to be similar for the different groups, we also determined how often failed grafts were found during angiography and the indications for the procedure. Failed grafts were more commonly found in patients operated using the BIMA and the IMA + RA graft groups compared with the IMA + SVG group. Assuming that graft failure is correlated with CAD symptoms, the groups with arterial grafts do not seem to exhibit a lower threshold for angiography. It is, however, not possible to determine the type of the failed graft and whether the failure occurred in the additional vein grafts rather than in the first or the second arterial conduit. It is also not possible to determine in what way failed grafts were responsible for the symptoms leading to the investigation. The different indications for the angiography were similar between the groups, with the exception of the high frequency of ST-segment elevation myocardial infarction for the BIMA graft group. We believe this finding further supports the impression that the incidences of angiography and reintervention in all 3 groups are similarly linked to the incidence of new coronary events and return of CAD symptoms.
CONCLUSIONS
Patients operated using arterial grafts as second conduits did not demonstrate a better outcome in any of the studied end-points when adjusting for risk factors. This study therefore does not provide evidence that more frequent use of arterial grafts as second conduits would lead to superior overall long-term outcome in the Swedish population having CABG. The inferior results after BIMA grafting could be the result of the increased complexity of the procedure in a setting where it is rarely performed, with an increase of technical failures during the operation and early recurrence of CAD symptoms. The results of the study further indicate that the RA grafts possibly should be preferred to the BIMA grafts as an alternative to SVG or when suitable vein grafts are not available. It is likely that there are other circumstances where arterial conduits in addition to left IMA should be used instead of vein grafts, but these remain to be defined.
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